COURSE UNIT TITLE

: CEREBROVASCULAR ATHEROSCLEROSIS

Description of Individual Course Units

Course Unit Code Course Unit Title Type Of Course D U L ECTS
SBK 5011 CEREBROVASCULAR ATHEROSCLEROSIS ELECTIVE 1 4 0 6

Offered By

Clinical Neuroscience

Level of Course Unit

Second Cycle Programmes (Master's Degree)

Course Coordinator

PROFESSOR ERDEM YAKA

Offered to

Clinical Neuroscience

Course Objective

The pathophysiology of atherosclerosis, the definition of atherothrombosis, modifiable risk factors, homocysteine and other genetic factors, lipid deficiency, imaging and measurement methods in cerebrovascular atherosclerosis, endarterectomy, other surgical methods for treatment, endovascular treatment, literature discussion and review of clinical applications.

Learning Outcomes of the Course Unit

1   Having knowledge about the definition of atherothrombosis, pathophysiology of atherosclerosis and several outcomes.
2   Having knowledge about he risk factors, homocysteine and other genetic factors. And having general knowledge about the treatment of atherosclerosis risk factors.
3   Having knowledge about imaging and measurement methods in cerebrovascular atherosclerosis and treatment methods
4   Being able to review and research literature about atherosclerosis
5   Being able to discuss the literature about atherosclerosis and review the applications.

Mode of Delivery

Face -to- Face

Prerequisites and Co-requisites

None

Recomended Optional Programme Components

None

Course Contents

Week Subject Description
1 Cerebral Vascular Anatomy (extra- and intracranial) and Application
2 Hemodynamics and Autoregulation and Application
3 The Pathophysiology of Atherosclerosis and Cardiac Outcomes and Practice
4 Peripheric Artery Outcomes of Atherosclerosis and Practice
5 Cerebral Outcomes of Atherosclerosis and Practice
6 Role of Thrombosis in Atherothrombotic Diseases and Practice
7 Genetic Factors in Pathophysiology of Atherosclerosis and Practice
8 midterm exam
9 Risk Factors of Atherosclerosis and Practice
10 Infection and Inflammation in Atherosclerosis and Practice
11 Homocystein and Atherosclerosis and Practice
12 Radiologic Methods in Atherosclerosis (Diagnosis and Invasive) and Practice
13 Treatment of Atherosclerosis Risk Factors (Primer and Seconder Protection) and Practice, Non-atherosclerotic Causes of Ischemic Cerebrovascular Diseases and Practice
14 Student's presentation

Recomended or Required Reading

Textbook(s): : Stroke, Eds. Barnet, Mohr, Stein, Yatsu
Primer on Cerebrovascular Diseases, Eds. Welch, Reis, Caplan, Siesjö, Weir, 1997
Supplementary Book(s): Iskemik inme, Kürşad Kutluk, 2004
Ateroskleroz, Emre Kumral, Birsen Ince, 2003
Serebrovasküler hastalıklar, Sevin Balkan, 2. Baskı, 2005
References: -
Materials: -

Planned Learning Activities and Teaching Methods

Lecture, homework assignments/projects and application

Assessment Methods

SORTING NUMBER SHORT CODE LONG CODE FORMULA
1 PRF PERFORMANCE
2 FIN FINAL EXAM
3 FCG FINAL COURSE GRADE PRF * 0.40+ FIN* 0.60
4 RST RESIT
5 FCGR FINAL COURSE GRADE PRF * 0.40+ RST* 0.60


Further Notes About Assessment Methods

None

Assessment Criteria

The knowledge of the pathophysiology of atherosclerosis, the definition of atherothrombosis, modifiable risk factors, homocysteine and other genetic factors, lipid deficiency, imaging and measurement methods in cerebrovascular atherosclerosis, endarterectomy, other surgical methods for treatment, endovascular treatment, literature discussion and review of clinical applications will be evaluated by mid-term and final exams

Language of Instruction

Turkish

Course Policies and Rules

To be announced.

Contact Details for the Lecturer(s)

412 4050

Office Hours

To be announced.

Work Placement(s)

None

Workload Calculation

Activities Number Time (hours) Total Work Load (hours)
Lectures 14 1 14
Tutorials 14 4 56
Preparations before/after weekly lectures 1 28 28
Preparation for midterm exam 1 28 28
Preparation for quiz etc. 1 20 20
0
Final 1 2 2
Midterm 1 2 2
TOTAL WORKLOAD (hours) 150

Contribution of Learning Outcomes to Programme Outcomes

PO/LOPO.1PO.2PO.3PO.4PO.5PO.6PO.7PO.8PO.9PO.10
LO.155
LO.25
LO.345
LO.45
LO.55